文献速递乳腺癌放疗

强效皮质类固醇乳膏预防性治疗改善放射性皮炎且与放疗方案无关:一项随机双盲研究

Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
PubMed 文献 · Radiother Oncol · 2016-11-29

该随机双盲研究纳入202例乳腺癌术后辅助放疗患者,比较倍他米松-17-戊酸酯乳膏与Essex®保湿霜预防急性放射性皮炎的效果。结果显示,强效类固醇组皮肤反应显著减少(p<0.001),且不受放疗方案影响,各亚组均一致。结论支持从放疗开始即预防性使用强效局部类固醇。

要点

  • 预防性使用强效局部类固醇可显著减少乳腺癌辅助放疗患者的急性放射性皮炎。
  • 类固醇的获益不受放疗方案(大分割或常规)影响,且在全部亚组中均显著。
  • 建议从放疗开始即常规预防性使用强效皮质类固醇乳膏。

核心结论

  • 预防性使用强效局部类固醇可有效预防和控制乳腺癌辅助放疗患者的急性放射性皮炎,且与放疗方案无关。

研究设计与样本

  • 双盲随机试验纳入202例乳腺癌术后接受辅助放疗的患者,随机分配至倍他米松-17-戊酸酯乳膏组或Essex®保湿霜组。

主要发现

  • 接受大分割放疗的患者皮肤反应少于常规放疗患者。
  • 强效类固醇治疗使皮肤反应在临床和统计学上均显著减少(p<0.001),无论放疗方案如何。
  • 类固醇的效果在所有亚组中均显著。

关键数值与推荐

  • 采用RTOG临床评分评估治疗,并记录患者症状。
  • 分析按放疗方案、解剖部位、皮肤类型、乳房大小和BMI进行分层。

临床怎么用

  • 应在临床常规中从放疗开始即预防性使用强效皮质类固醇乳膏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The study will test the hypothesis that preventive topical steroid treatment instituted from start of radiotherapy can ameliorate acute radiation dermatitis. Subgroups of increased risk of dermatitis are included. MATERIAL AND METHODS: A double blinded randomized trial in patients with breast cancer receiving adjuvant radiotherapy (RT) after surgery. In total, 202 patients were randomized to betamethasone-17-valerate cream or Essex® cream, a moisturizer. Treatment was assessed by RTOG clinical scoring. Patients' symptoms were recorded. The analyses were stratified for RT schedules as well as for anatomical sites, skin type, breast size and BMI. Patients treated the irradiated area during the radiation period and two weeks following cessation of radiation. RESULTS: Patients receiving hypofraction RT developed less skin reactions than those treated with conventional RT. Treatment with a potent steroid resulted in clinically and statistically significantly less skin reactions (p<0.001) regardless of RT schedule. The effect of the steroid was prominent in all subgroups. CONCLUSION: Prophylactic treatment with a strong local steroid is efficient for the prevention and control of acute radiation dermatitis in breast cancer patients treated with adjuvant RT, independent of RT schedule. Preventive application of a potent corticosteroid cream should be used in the routine and instituted at the start of RT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ulff E, Maroti M, Serup J, et al. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study. Radiother Oncol. 2016. PMID: 27913066. doi:10.1016/j.radonc.2016.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。